Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer.
about
Combination chemotherapy versus single-agent chemotherapy during preoperative chemoradiation for resectable rectal cancerPreoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancerCombination chemotherapy versus single agent chemotherapy during preoperative chemoradiation for resectable rectal cancerPreoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancerCapecitabine in the management of colorectal cancerTargeting cancers in the gastrointestinal tract: role of capecitabineRegional hyperthermia added to intensified preoperative chemo-radiation in locally advanced adenocarcinoma of middle and lower rectum.The role of capecitabine in locally advanced rectal cancer treatment: an update.Rectal cancer treatment: improving the picture.Recent advances in the management of carcinoma of the rectumPreliminary results of phase I trial of oral uracil/tegafur (UFT), leucovorin plus irinotecan and radiation therapy for patients with locally recurrent rectal cancer.Efficacy endpoints of radiation therapy group protocol 0247: a randomized, phase 2 study of neoadjuvant radiation therapy plus concurrent capecitabine and irinotecan or capecitabine and oxaliplatin for patients with locally advanced rectal cancer.Radiation Therapy Oncology Group 0247: a randomized Phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancerEarly changes in apparent diffusion coefficient predict the quantitative antitumoral activity of capecitabine, oxaliplatin, and irradiation in HT29 xenografts in athymic nude mice.Chemotherapy Alone for Patients With Stage II/III Rectal Cancer Undergoing Radical SurgeryPreoperative chemoradiotherapy with capecitabine and oxaliplatin in locally advanced rectal cancer. A phase I-II multicenter study of the Dutch Colorectal Cancer GroupConcurrent chemoradiation of metastases with capecitabine and oxaliplatin and 3D-CRT in patients with oligometastatic colorectal cancer: results of a phase I studyCapecitabine: effective oral fluoropyrimidine chemotherapy.Neoadjuvant chemotherapy prior to preoperative chemoradiation or radiation in rectal cancer: should we be more cautious?Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy.Anal cancer: current and future methodology.Phase II study of capecitabine and oxaliplatin given prior to and concurrently with preoperative pelvic radiotherapy in patients with locally advanced rectal cancerA phase I/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group Study.Postoperative chemoradiotherapy in gastric cancer -- a Phase I/II dose-finding study of radiotherapy with dose escalation of cisplatin and capecitabine chemotherapyCPT-11 and concomitant hyperfractionated accelerated radiotherapy induce efficient local control in rectal cancer patients: results from a phase II.MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins?Biweekly oxaliplatin, raltitrexed, 5-fluorouracil and folinic acid combination chemotherapy during preoperative radiation therapy for locally advanced rectal cancer: a phase I-II studyPhase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck.Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer.A phase I/II study of oxaliplatin when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group (CCOG) studyOxaliplatin combined with infusional 5-fluorouracil and concomitant radiotherapy in inoperable and metastatic rectal cancer: a phase I trialIntensified concurrent chemoradiotherapy with 5-fluorouracil and irinotecan as neoadjuvant treatment in patients with locally advanced rectal cancerA review of the role of capecitabine in the treatment of colorectal cancer.Cetuximab in the treatment of metastatic colorectal cancer.Phase II trial of preoperative radiochemotherapy with concurrent bevacizumab, capecitabine and oxaliplatin in patients with locally advanced rectal cancer.Capecitabine and timing of radiotherapy during preoperative chemoradiation for rectal cancer.Capecitabine plus oxaliplatin for the treatment of colorectal cancer.Definitive chemoradiotherapy with capecitabine and cisplatin in patients with esophageal cancer: a pilot studyAccomplishments in 2007 in the management of localized gastric cancer.Potential benefits of integration of therapies with chemoradiation in rectal cancer.
P2860
Q24186443-E6C90512-B84F-42F5-BC61-66FA2ADB4923Q24200568-9D1667C3-9493-454D-93B2-4CB94F3EC759Q24235103-84C26562-BC99-4F58-9E5F-805178F4F848Q24241258-32D9C9D6-1B7C-4AB0-B76D-68AA35ADC36BQ24633039-18A15938-ABE8-4BE1-B83B-9D89E5F83185Q33916021-180B3CD8-51E4-4576-AE5A-55B69DCD168EQ34098024-C4DF5FB6-0405-4CCF-BA2E-85352CD6F9B2Q34276823-FD5921F3-849B-42D1-8BB0-2E827770D0E2Q34382761-4C5AB58A-E175-4014-930E-863C5BEE6A9AQ35026254-2A40CCA0-3EEC-40B7-92B3-91067CFE025BQ35171932-0AAAC977-F0EA-4182-BD47-A942D3A2802DQ35269337-2786B758-BA3A-4177-BF4D-4559A725E10DQ35528886-C23609F0-30BA-456F-BE55-846FF7A0F41BQ35812742-BF2EEA90-D218-4834-81E9-97A2B069B2BAQ35820586-AE8AAED0-41F8-4AD9-94EE-36252BBCD36FQ36087573-C1010066-5F5C-42E9-A0BB-A92C3836E1E4Q36112410-86A6D73C-A2D5-4ECE-9640-20B639CE31C4Q36164013-45C14A3C-1205-473C-95B0-BEF5FE5515B5Q36390229-59BCCC72-D597-488A-A525-01A27C7CAAC2Q36487139-1AA9ECF4-42E2-44C7-B320-5CF100588BD4Q36581056-5820AE73-40EA-4884-8881-488B9FC376B1Q36608511-9E1A6A4D-C199-4910-BAC3-7B62318BA6A8Q36609922-633FA8FA-80A3-4442-B13D-5D77D9302E92Q36611129-33436DC4-BAF2-477F-AFBA-E0D58C2F6B83Q36611654-88BE4385-2E9B-4397-859B-C4C2319AED04Q36613720-D420FCF4-4393-4013-9B09-74A540C04E0FQ36614369-90A66B33-0CB7-4C7B-B2D1-FDD831F8C6B9Q36614888-6CAEBFF4-DB37-4BC9-970F-1D037FD33D70Q36615060-A22AB104-C017-4E98-A584-1B9ECF838923Q36615549-869248DE-3C6D-4B7A-A9EF-B9BB5D17541DQ36616213-8B8F2430-C4F8-482C-AC58-D257FF62CF54Q36616544-1A234798-CF8C-4BC8-9E85-E18BA4938C8DQ36661290-0ED42DCE-E9B7-4355-B917-C33A2C5F8FD1Q36717359-653D0691-A4A4-46AA-8707-FB93C17DDA28Q36921895-050D4A4F-BEA7-43E4-A816-74EF914E0C3BQ37077342-A6D740B9-E6F3-46E3-9C7E-B03CD3E2003EQ37085987-896B147D-C27D-4082-807A-D35699029041Q37116834-3DB70086-EFFD-48C5-8743-D8AA46E62AA0Q37149160-F7FD8D03-8CEB-4495-996E-346DAEF8A6A0Q37153308-740E45DD-A78F-4786-BDFB-FF10DDCCCD8A
P2860
Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer.
@en
Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer.
@nl
type
label
Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer.
@en
Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer.
@nl
prefLabel
Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer.
@en
Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer.
@nl
P2093
P356
P1476
Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer.
@en
P2093
Gerhard G Grabenbauer
Hans-Joachim Schmoll
Rolf Sauer
Thomas Papadopoulos
Werner Hohenberger
P304
P356
10.1200/JCO.2003.02.505
P407
P50
P577
2003-08-01T00:00:00Z